The University of Kansas Cancer Center at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
The University of Kansas Cancer Center brings 8 presentations to ASH 2026 in New Orleans. Its research centres on lymphoma, leukemia and transplant outcomes. Work covers golcadomide with Pola-R-CHP, TP53 changes in mantle cell lymphoma and engineered gamma-delta T cells after transplant.
| Organization | ASH 2026 Attendance |
|---|---|
The University of Kansas Cancer Center Kansas City, KS | |
NCI-designated comprehensive cancer center of the University of Kansas, serving the Kansas City region. | Symposium Fri Dec 11 7:00pm–10:00pm Addressing Community Oncologists’ Questions About Novel Therapies in Non-Hodgkin Lymphoma – What Clinicians Want To Know Answers to community oncologists' most pressing questions about new drugs for non-Hodgkin lymphoma, drawn from a survey and reviewed against current research. Poster Sat Dec 12 5:30pm–7:30pm Poster Sat Dec 12 5:30pm–7:30pm Poster Sat Dec 12 5:30pm–7:30pm Poster Sun Dec 13 6:00pm–8:00pm Poster Sun Dec 13 6:00pm–8:00pm Oral Mon Dec 14 2:45pm–4:15pm Oral Mon Dec 14 2:45pm–4:15pm |
Find decision makers at The University of Kansas Cancer Center
Tell us what you sell and we’ll find the people at The University of Kansas Cancer Center most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction